Moderna | MRNA - Assets



Moderna reported $12.01B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Acadia Pharmaceuticals USD 1.23B 93.19M Jun/2025
Adcock Ingram Holdings ZAR 8.74B 388.13M Dec/2024
Agios Pharmaceuticals USD 1.47B 84.28M Jun/2025
Alnylam Pharmaceuticals USD 4.57B 352.21M Jun/2025
Amgen USD 87.9B 1.47B Jun/2025
Arrowhead Research USD 1.38B 192.89M Jun/2025
Biogen USD 28.33B 297.1M Jun/2025
BioMarin Pharmaceutical USD 7.46B 309.33M Jun/2025
Celltrion KRW 20.96T 96.41B Mar/2025
Cspc Pharmaceutical CNY 44.39B 3.51B Dec/2024
Dianthus Therapeutics USD 326.08M 47.93M Jun/2025
Divis Laboratories Ltd 169.32B 13.46B Mar/2025
Gilead Sciences USD 55.72B 713M Jun/2025
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
Incyte USD 5.82B 71.99M Jun/2025
Ionis Pharmaceuticals USD 2.99B 172.18M Jun/2025
Kangmei Pharma CNY 13.64B 69.1M Jun/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Laboratorios Farma EUR 869.6M 37.58M Jun/2025
Malin Corporation EUR 198.5M 70.1M Dec/2024
Moderna USD 12.01B 694M Jun/2025
Organigram Holdings CAD 564.62M 85.41M Jun/2025
Pharma Mar EUR 348.25M 14.75M Jun/2025
Qiagen NV USD 5.82B 278.39M Jun/2025
Regeneron Pharmaceuticals USD 38.22B 674M Jun/2025
Sarepta Therapeutics USD 3.68B 214.43M Jun/2025
Sartorius EUR 10.03B 85.1M Jun/2025
Sino Biopharmaceutical CNY 65.41B 1.3B Dec/2024
Tilray USD 4.19B 70.11M Nov/2024
Ultragenyx Pharmaceutical USD 1.31B 5.66M Jun/2025
United Therapeutics USD 7.91B 164.1M Jun/2025
Vertex Pharmaceuticals USD 24.04B 1.16B Jun/2025
Zz Pientze Pharmaceu 18.71B 224.21M Jun/2025